Immune Checkpoint Inhibitors Significantly Increase Myocarditis Risk in NSCLC Patients
May 16, 2025
BUFFALO, NY — May 16, 2025 — A new editorial was published in Volume 12 of Oncoscience on May 2, 2025, titled “Immune checkpoint inhibitors and myocarditis: Lessons from a nationwide cohort study." continue reading »